Assessment of the clinical effectiveness of pulmonary artery catheters in management of patients in intensive care (PAC-Man): a randomised controlled trial.
By S. Harvey, D. Harrison, Mervyn Singer, J. Ashcroft, Carys Jones, Diana Elbourne, W. Brampton, Dewi Williams, D. Young, K. Rowan. The Lancet, 2005
1,004 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/3695b51e19c42ba92b10917756c5f4348ce091e0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial. (2005, neutral): “Edema§ 134 (67) 41 (20) −93 (46)† 139 (68) 42 (21) −97 (48)†”
- Adjusting treatment effect estimates by post‐stratification in randomized experiments (2013, critical): “However, a randomized controlled trial (PAC-Man) found no difference in mortality between PAC and no-PAC groups (Harvey et al., 2005), which substantiated the concern that the observational results were subject to selection bias (Sakr et al., 2005).”
- Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. (2006, background): “It is this latter setting in which controversy persists with respect to the usefulness and safety of pulmonary artery catheters (29,37,38).”
- Lasso adjustments of treatment effect estimates in randomized experiments (2015, methodology): “To ground our discussion, we examine a randomized trial of the Pulmonary Artery Catheter (PAC) that was carried out in 65 intensive care units in the UK between 2001 and 2004, called PAC-man [2].”
- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 (2017, methodology): “In a trial of 35 patients with septic shock and acute respiratory distress syndrome (ARDS) randomized to levosimendan or placebo, levosimendan improved right ventricular performance and mixed venous oxygen saturation compared to placebo (291).”